Advertisement PPD Expands Drug Development Services In Asia Pacific - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

PPD Expands Drug Development Services In Asia Pacific

In response to growing client demand in Asia Pacific, PPD has expanded its Phase II-IV clinical development services by opening new offices in Philippines and India. PPD is expected to provide clinical management services in key therapeutic areas from both locations.

PPD is expecting that the offices will strengthen its full range of drug discovery and development services and continue to position it to capitalise on the growth of the outsourcing market in Asia Pacific.

PPD has recently expanded in this region through acquisitions of Excel, one of the contract research organisations in China and BioDuro, a drug discovery outsourcing company.

Lesley Gerrard, director of clinical management of Melbourne, Australia office at PPD, said: “The recent opening of the Manila office demonstrates PPD’s commitment to the growth and development of emerging markets in Southeast Asia and to further exploration of the opportunities that exist within this region.”

Denzel Benjamin, director of clinical management of Bangalore office at PPD: said: “India is expected to conduct nearly 5% of global trials by 2010, and the opening of our Bangalore office advances our plans for expansion in India. This office provides us easy access to all of our sites across south India, which means cost savings for our clients and greater efficiencies for PPD.”